167 related articles for article (PubMed ID: 18638564)
1. Prostaglandin F(2alpha) negatively regulates bone resorption in murine osteoclast development.
Kamon M; Fujita D; Goto N; Amano H; Sakamoto K
Prostaglandins Other Lipid Mediat; 2008 Dec; 87(1-4):26-33. PubMed ID: 18638564
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia is a major stimulator of osteoclast formation and bone resorption.
Arnett TR; Gibbons DC; Utting JC; Orriss IR; Hoebertz A; Rosendaal M; Meghji S
J Cell Physiol; 2003 Jul; 196(1):2-8. PubMed ID: 12767036
[TBL] [Abstract][Full Text] [Related]
3. Bone cells required for osteoclastic resorption but not for osteoclastic differentiation.
Owens JM; Gallagher AC; Chambers TJ
Biochem Biophys Res Commun; 1996 May; 222(2):225-9. PubMed ID: 8670187
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow cells produce soluble factors that inhibit osteoclast activity.
Ninomiya JT; Bi Y; Banks MA; Lavish SA; Goldberg VM; Greenfield EM
J Orthop Res; 1999 Jan; 17(1):51-8. PubMed ID: 10073647
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin F(2alpha) regulates cytokine responses of mast cells through the receptors for prostaglandin E.
Kaneko I; Hishinuma T; Suzuki K; Owada Y; Kitanaka N; Kondo H; Goto J; Furukawa H; Ono M
Biochem Biophys Res Commun; 2008 Mar; 367(3):590-6. PubMed ID: 18190789
[TBL] [Abstract][Full Text] [Related]
6. Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.
Kim MH; Ryu SY; Bae MA; Choi JS; Min YK; Kim SH
Food Chem Toxicol; 2008 Nov; 46(11):3375-82. PubMed ID: 18786594
[TBL] [Abstract][Full Text] [Related]
7. Effects of neridronic acid on osteoclasts derived by physiological dual-cell cultures.
Nicolin V; Bareggi R; Baldini G; Bortul R; Martinelli B; Narducci P
Acta Histochem; 2007; 109(5):397-402. PubMed ID: 17574655
[TBL] [Abstract][Full Text] [Related]
8. Bimodal actions of reactive oxygen species in the differentiation and bone-resorbing functions of osteoclasts.
Kim H; Kim IY; Lee SY; Jeong D
FEBS Lett; 2006 Oct; 580(24):5661-5. PubMed ID: 16996506
[TBL] [Abstract][Full Text] [Related]
9. VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin.
Yang Q; McHugh KP; Patntirapong S; Gu X; Wunderlich L; Hauschka PV
Matrix Biol; 2008 Sep; 27(7):589-99. PubMed ID: 18640270
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of (-)-saucerneol on osteoclast differentiation and bone pit formation.
Kim SN; Kim MH; Kim YS; Ryu SY; Min YK; Kim SH
Phytother Res; 2009 Feb; 23(2):185-91. PubMed ID: 18690659
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
Axmann R; Böhm C; Krönke G; Zwerina J; Smolen J; Schett G
Arthritis Rheum; 2009 Sep; 60(9):2747-56. PubMed ID: 19714627
[TBL] [Abstract][Full Text] [Related]
13. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
Bonnelye E; Chabadel A; Saltel F; Jurdic P
Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546
[TBL] [Abstract][Full Text] [Related]
14. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.
Lee MS; Kim HS; Yeon JT; Choi SW; Chun CH; Kwak HB; Oh J
J Immunol; 2009 Sep; 183(5):3390-9. PubMed ID: 19641137
[TBL] [Abstract][Full Text] [Related]
15. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
Tsuji-Naito K
Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786
[TBL] [Abstract][Full Text] [Related]
16. A novel PPARgamma agonist, KR62776, suppresses RANKL-induced osteoclast differentiation and activity by inhibiting MAP kinase pathways.
Park JY; Bae MA; Cheon HG; Kim SS; Hong JM; Kim TH; Choi JY; Kim SH; Lim J; Choi CH; Shin HI; Kim SY; Park EK
Biochem Biophys Res Commun; 2009 Jan; 378(3):645-9. PubMed ID: 19059209
[TBL] [Abstract][Full Text] [Related]
17. The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell.
Bar-Shavit Z
J Cell Biochem; 2007 Dec; 102(5):1130-9. PubMed ID: 17955494
[TBL] [Abstract][Full Text] [Related]
18. The Rho GTPase Wrch1 regulates osteoclast precursor adhesion and migration.
Brazier H; Pawlak G; Vives V; Blangy A
Int J Biochem Cell Biol; 2009 Jun; 41(6):1391-401. PubMed ID: 19135548
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha.
van Beek EM; de Vries TJ; Mulder L; Schoenmaker T; Hoeben KA; Matozaki T; Langenbach GE; Kraal G; Everts V; van den Berg TK
FASEB J; 2009 Dec; 23(12):4081-90. PubMed ID: 19667119
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kappaB.
Lin RW; Chen CH; Wang YH; Ho ML; Hung SH; Chen IS; Wang GJ
Biochem Biophys Res Commun; 2009 Feb; 379(4):1033-7. PubMed ID: 19150340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
